Carmat SA (EPA:ALCAR)

Market Cap	46.34M
Revenue (ttm)	7.00M
Net Income (ttm)	-51.40M
Shares Out	58.81M
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	62,038
Average Volume	121,609
Open	0.8000
Previous Close	0.7880
Day's Range	0.7921 - 0.8030
52-Week Range	0.6930 - 4.4000
Beta	1.48
RSI	37.59
Earnings Date	Apr 30, 2025

About Carmat

Carmat SA designs and develops total artificial heart for people suffering from end-stage biventricular heart failure in France and internationally. Its product includes Aeson, an active implantable medical device intended to replace the ventricles of the native heart in patients suffering from advanced heart failure. The company was incorporated in 2008 and is headquartered in Vélizy-Villacoublay, France.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2008
• Employees: 200
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALCAR

Financial Performance

In 2024, Carmat's revenue was 7.00 million, an increase of 82.43% compared to the previous year's 3.84 million. Losses were -51.40 million, -4.58% less than in 2023.